Principal Financial Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $504K | Sell |
|
|||||
|
2025
Q2 | $387K | Buy |
|
|||||
|
2025
Q1 | $19.1K | Buy |
|
|||||
|
2024
Q4 | $26.6K | Sell |
|
|||||
|
2024
Q3 | $25.3K | Sell |
|
|||||
|
2024
Q2 | $45.4K | Sell |
|
|||||
|
2024
Q1 | $78.1K | Sell |
|
|||||
|
2023
Q4 | $101K | Sell |
|
|||||
|
2023
Q3 | $33.7K | Buy |
|
|||||
|
2023
Q2 | $43.8K | Buy |
|
|||||
|
2023
Q1 | $30.7K | Sell |
|
|||||
|
2022
Q4 | $129K | Buy |
|
|||||
|
2022
Q3 | $113K | Sell |
|
|||||
|
2022
Q2 | $108K | Buy |
|
|||||
|
2022
Q1 | $49K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $207K | Sell |
|
|||||
|
2020
Q2 | $518K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $236K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $334K | Buy |
|
|||||
|
2017
Q4 | $274K | Buy |
|